TY  - GEN
AU  - Bagheri,Abouzar
AU  - Soheili,Zahra-Soheila
AU  - Ahmadieh,Hamid
AU  - Samiei,Shahram
AU  - Sheibani,Nader
AU  - Astaneh,Shamila Darvishalipour
AU  - Kanavi,Mozhgan Rezaei
AU  - Mohammadian,Azam
TI  - Simultaneous application of bevacizumab and anti-CTGF antibody effectively suppresses proangiogenic and profibrotic factors in human RPE cells
SN  - 1090-0535
PY  - 2015///0911
KW  - Actins
KW  - genetics
KW  - Angiogenesis Inhibitors
KW  - pharmacology
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibodies, Neutralizing
KW  - Apoptosis
KW  - drug effects
KW  - Bevacizumab
KW  - Cathepsin D
KW  - Cell Proliferation
KW  - Connective Tissue Growth Factor
KW  - antagonists & inhibitors
KW  - Drug Synergism
KW  - Epithelial Cells
KW  - cytology
KW  - Gene Expression Regulation
KW  - Humans
KW  - Matrix Metalloproteinase 2
KW  - Matrix Metalloproteinase 9
KW  - Primary Cell Culture
KW  - Retinal Pigment Epithelium
KW  - Signal Transduction
KW  - Tissue Inhibitor of Metalloproteinase-1
KW  - Tissue Inhibitor of Metalloproteinase-2
KW  - Transcription, Genetic
KW  - Vascular Endothelial Growth Factor A
KW  - Vascular Endothelial Growth Factor Receptor-1
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ER  -